NCT03417466View on ClinicalTrials.gov

A Pivotal Study to Evaluate Enlite™ Sensor Performance With iPro™2 in China

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

September 20, 2018

Study Completion Date

September 20, 2018

Conditions
Diabetes Mellitus
Interventions
DEVICE

Enlite 1 connected to iPro2 recorder

Use Enlite Sensor over 144 hours (6 days) when inserted in the abdomen and used with the iPro2 in subjects age 14 - 75 years.

Trial Locations (3)

100700

PLA Army General Hospital, Beijing

200233

Shanghai Sixth People's Hospital, Shanghai

310016

Sir Run Run Shaw Hospital School of Medicine Zhejiang University, Hangzhou

All Listed Sponsors
lead

Medtronic Diabetes

INDUSTRY

NCT03417466 - A Pivotal Study to Evaluate Enlite™ Sensor Performance With iPro™2 in China | Biotech Hunter | Biotech Hunter